Cytochrome P4502C9 induces cycloxygenase-2 expression in endothelial cells

被引：0
|
作者：
Michaelis, UR [1 ]
Fisslthaler, B [1 ]
Fleming, I [1 ]
Busse, R [1 ]
机构：
[1] Klinikum JWG Univ, Frankfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2003年 / 24卷
关键词：
D O I：
10.1016/S0195-668X(03)93694-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [21] Study of recombinant cytochrome P4502C9 activity with diclofenac by MEKC
    Konecny, Jiri
    Jurica, Jan
    Tomandl, Josef
    Glatz, Zdenek
    ELECTROPHORESIS, 2007, 28 (08) : 1229 - 1234
  • [22] Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite
    Bajpai, M
    Roskos, LK
    Shen, DD
    Levy, RH
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (12) : 1401 - 1403
  • [23] Cytochrome P4502C9 mediated metabolism in people with and without cancer
    Shord, S. S.
    Cavallari, L. H.
    Viana, M. A. G.
    Momary, K.
    Neceskas, J.
    Molokie, R. E.
    Deyo, K.
    Patel, S. R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (07) : 365 - 374
  • [24] Effects of cytochrome P4502C9 polymorphisms on phenprocoumon anticoagulation status
    Schalekamp, T
    Oosterhof, M
    van Meegen, E
    van der Meer, FJM
    Conemans, J
    Hermans, M
    Meijerman, I
    de Boer, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 409 - 417
  • [25] Frequency of cytochrome P4502C9 mutant alleles in a Korean population
    Yoon, YR
    Shon, JH
    Kim, MK
    Lim, YC
    Lee, HR
    Park, JY
    Cha, IJ
    Shin, JG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (03) : 277 - 280
  • [26] Development of a combined protein and pharmacophore model for cytochrome P4502C9
    de Groot, MJ
    Alex, AA
    Jones, BC
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) : 1983 - 1993
  • [27] Crystallization of human P4502C9
    Wester, MR
    Stout, CD
    Schoch, G
    Yano, JK
    Johnson, EF
    FASEB JOURNAL, 2003, 17 (04): : A609 - A609
  • [28] The impact of CYP2C9 genetics and oral contraceptives on cytochrome P4502C9 phenotype
    Sandberg, M
    Johansson, I
    Christensen, M
    Rane, A
    Eliasson, E
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (05) : 484 - 489
  • [29] A virtual screening filter for identification of cytochrome P4502C9 (CYP2C9) inhibitors
    Byvatov, Evgeny
    Baringhaus, Karl-Heinz
    Schneider, Gisbert
    Matter, Hans
    QSAR & COMBINATORIAL SCIENCE, 2007, 26 (05): : 618 - 628
  • [30] Substance P-induced cycloxygenase-2 expression in polymorphonuclear cells
    Gallicchio, M.
    Benetti, E.
    Rosa, A. C.
    Fantozzi, R.
    INFLAMMATION RESEARCH, 2008, 57 (Suppl 1) : S17 - S18
12345